Low-Dose Decitabine in Treating Patients With Symptomatic Myelofibrosis

NCT00630994 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Stopped due to slow accrual

Conditions

Chronic Myeloproliferative Disorders
Secondary Myelofibrosis

Interventions

DRUG: Dacogen

Sponsor

Mayo Clinic

Collaborators

[object Object]